Liquiritigenin alleviates mechanical and cold hyperalgesia in a rat neuropathic pain model

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Chen, Li ^a   Chen, Wei ^a   Qian, Xiao ^a   Fang, Yun ^a   Zhu, Naijun ^a  

^a Suzhou Center for Disease Control   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; FLAVANONE DERIVATIVE; LIQUIRITIGENIN;

ANIMAL; DRUG SCREENING; HYPERALGESIA; MALE; NEURALGIA; ROTAROD TEST; SPRAGUE DAWLEY RAT;

ANALGESICS; ANIMALS; DRUG EVALUATION, PRECLINICAL; FLAVANONES; HYPERALGESIA; MALE; NEURALGIA; RATS, SPRAGUE-DAWLEY; ROTAROD PERFORMANCE TEST;

EID: 84904498133     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05676     Document Type: Article

References (16)

1. Bouhassira, D., Lanteri-Minet,M., Attal, N., Laurent, B. & Touboul, C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136, 380-387 (2008).
2. Loeser, J. D. & Treede, R. D. The Kyoto protocol of IASP Basic Pain Terminology. Pain 137, 473-477 (2008).
3. Treede, R. D. et al.Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology 70, 1630-1635 (2008).
4. Attal, N. et al. Neuropathic pain: Are there distinct subtypes depending on the aetiology or anatomical lesion? Pain 138, 343-353 (2008).
5. Attal, N. et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13, 1153-1169 (2006).
6. Attal, N. et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 17, 1113-e1188 (2010).
7. Bennett, G. J. & Xie, Y. K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33, 87-107 (1988).
8. Maves, T. J., Pechman, P. S., Gebhart, G. F. & Meller, S. T. Possible chemical contribution from chromic gut sutures produces disorders of pain sensation like those seen in man. Pain 54, 57-69 (1993).
9. Vriens, J. et al. TRPM3 is a nociceptor channel involved in the detection of noxious heat. Neuron 70, 482-494 (2011).
10. Straub, I. et al. Flavanones that selectively inhibit TRPM3 attenuate thermal nociception in vivo. Mol Pharmacol 84, 736-750 (2013).
11. Dixon, W. J. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20, 441-462 (1980).
12. Hargreaves, K., Dubner, R., Brown, F., Flores, C. & Joris, J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77-88 (1988).
13. Majeed, Y. et al. Rapid and contrasting effects of rosiglitazone on transient receptor potential TRPM3 and TRPC5 channels. Mol Pharmacol 79, 1023-1030 (2011).
14. Klose, C. et al. Fenamates as TRP channel blockers: Mefenamic acid selectively blocks TRPM3. Br J Pharmacol 162, 1757-1769 (2011).
15. Oberwinkler, J., Lis, A., Giehl, K. M., Flockerzi, V. & Philipp, S. E. Alternative splicing switches the divalent cation selectivity of TRPM3 channels. J Biol Chem 280, 22540-22548 (2005).
16. Fruhwald, J. et al. Alternative splicing of a protein domain indispensable for function of transient receptor potential melastatin 3 (TRPM3) ion channels. J Biol Chem 287, 36663-36672 (2012).